Clearbridge Health (SGX:1H3) ROCE % : -184.26% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Clearbridge Health ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Clearbridge Health's annualized ROCE % for the quarter that ended in Dec. 2023 was -184.26%.

Clearbridge Health ROCE % Historical Data

The historical data trend for Clearbridge Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearbridge Health ROCE % Chart

Clearbridge Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-15.36

5.90

-16.58

-17.49

-93.26

Clearbridge Health Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial													-19.04	-24.60	-10.39	-4.79	-184.26

Clearbridge Health ROCE % Calculation

Clearbridge Health's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-33.612	/	( ( (58.178 - 5.1)	+	(23.918 - 4.912) )	/ 2 )
	=	-33.612	/	( (53.078	+	19.006)	/ 2 )
	=	-33.612	/	36.042
	=	-93.26 %

Clearbridge Health's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	-64.724	/	( ( (55.537 - 4.289)	+	(23.918 - 4.912) )	/ 2 )
	=	-64.724	/	( ( 51.248	+	19.006 )	/ 2 )
	=	-64.724	/	35.127
	=	-184.26 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Clearbridge Health (SGX:1H3) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Clearbridge Health ROCE % Related Terms

Thank you for viewing the detailed overview of Clearbridge Health's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Clearbridge Health (SGX:1H3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Clearbridge Health Ltd (SGX:1H3) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

37 Jalan Pemimpin, No. 08-05 Mapex, Singapore, SGP, 577177

Website

https://www.clearbridgehealth.com

Clearbridge Health Ltd provides health care services. It is an integrated healthcare group with end-to-end diagnostic abilities, deploying non-invasive tests to identify and manage illness. The segments of the company are Strategic investments; Healthcare systems; Medical clinics; Corporate segment and Investment. It derives key revenue from the Healthcare systems and Medical clinics. The Healthcare systems segment involves, provision of diagnostic services and manufacturing of and research and development on diagnostic related products, and provision of renal care services by partnering with medical device equipment manufacturers and hospitals. The Medical clinics segment involves, provision of general medical and clinical services. The group has a business presence in all over the world.

Clearbridge Health (SGX:1H3) Headlines

No Headlines